Upcoming IPO: Hexagon Nutrition has announced the price band for its upcoming initial public offering (IPO) at ₹42-45 per share. The mainboard issue is set to hit the primary market next week on June 5. The offer will close for bidding on June 9.
The anchor book for Hexagon Nutrition IPO will open on June 4.
The company is looking to raise ₹139 crore at the upper end of the price band. The IPO is entirely an offer for sale of 3.08 crore shares, meaning that no proceeds will be received by the company. Arun Purushottam Kelkar, Subhash Purushottam Kelkar, Aditya Kelkar and Nutan Subhash Kelkar are the promoter selling shareholders.
The company said one of its objectives is to achieve the benefits of listing the equity shares on the stock exchanges.
Investors can apply for Hexagon Nutrition IPO in lots of 333 shares, requiring a minimum investment of ₹14,985 at the upper end of the price.
According to the company’s red herring prospectus, 50% of the offer is reserved for qualified institutional buyers (QIBs), 15% for non-institutional investors and the remaining 35% for retail investors.
About the company
Established in 1993, Hexagon Nutrition is a research-oriented pure-play nutrition player, offering products across a broad spectrum, ranging from micronutrient premixes to therapeutic and clinical nutrition products. It is also among the largest premix players in India, supplying customised vitamin and mineral premixes to leading Indian and multinational FMCG companies.
Its product portfolio caters to multiple nutritional needs, including food fortification, therapeutic nutrition, clinical nutrition, and the alleviation of malnutrition. The company operates as a fully integrated player across the entire value chain, from research and product development to manufacturing and marketing, with a strong focus on quality.
The company has a pan-India presence, and its products were exported to more than 75 countries during the nine-month period ended December 31, 2025, as well as in Fiscals 2023, 2024, and 2025, according to the RHP.
It operates three manufacturing facilities in India, located in Nashik (Maharashtra), Chennai (Tamil Nadu), and Thoothukudi (Tamil Nadu), along with one international manufacturing facility in Tashkent, Uzbekistan. Two of its Indian manufacturing facilities, situated in SEZ zones in Chennai and Thoothukudi, provide strategic advantages such as proximity to major ports and access to duty-free imports.
The shares of Hexagon Nutrition are slated to list on BSE and NSE, with the tentative listing date set as June 12. Cumulative Capital and Catalyst Capital Partners are the book-running lead managers (BRLMs) and KFin Technologies is the registrar for the offer.
Disclaimer: This story is for educational purposes only. The views and recommendations made above are those of individual analysts or broking companies, and not of Mint. We advise investors to check with certified experts before making any investment decisions.
